Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer

التفاصيل البيبلوغرافية
العنوان:	Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
المؤلفون:	Liveringhouse, Casey L. ^, Latifi, Kujtim ^, Asous, Amalin G. ^, Lam, Nghi B. ^, Rosenberg, Stephen A. ^, Dilling, Thomas J. ^, MacMillan, Gretchen V. ^, Chiappori, Alberto A., Haura, Eric B., Creelan, Ben, Gray, Jhanelle E., Tanvetyanon, Tawee, Shafique, Michael R., Saltos, Andreas N., Weiner, Ashley A., Clarke, Jeffrey, Kelsey, Christopher R., Kim, Sungjune ^, Caudell, James J. ^, Rose, Trevor A., Conejo-Garcia, Jose R., Li, Jiannong, Schell, Michael J., Antonia, Scott J., Perez, Bradford A. ^
المصدر:	In International Journal of Radiation Oncology, Biology, Physics 15 July 2023 116(4):837-848
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	03603016
DOI:	10.1016/j.ijrobp.2023.01.006